Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Genomic and Proteomic Tool Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global genomic and proteomic tool market looks promising with opportunities in agriculture and animal husbandry, drug discovery, forensics, proteogenomics research, disease identification, diagnostic and control applications. The global genomic and proteomic tool market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are increasing prevalence of cancer, diabetes, and cardiovascular diseases, rising demand for personalized medicines, and increasing research activities related to genomics and proteomics.

A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genomic and proteomic tool market report, please download the report brochure.


 
Genomic and Proteomic Tool Market by Technology and Product Form, Type and Application
 


In this market, next-generation sequencing is the largest type of genomic and proteomic, whereas proteogenomic research is the largest application. Growth in various segments of the genomic and proteomic market are given below:
 
Genomic and Proteomic Tool Market by Segments

 
 
The study includes trends and forecast for the global genomic and proteomic tool market by technology and product, type, application, and region as follows:
 
By Technology and Product Form [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Sequencing Technologies
  • Sangers Sequencing & Next Generation Sequencing
  • PCR (Polymerase Chain Reaction) Technologies
  • Flow Cytometry
  • Mass Spectrometry
  • Nucleic Acid Sample Preparation Technologies
  • Separation Technologies

By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Sample Preparation
  • Electrophoresis
  • Biochips and Microarrays
  • Chromatography
  • Mass Spectrometry
  • Thermal Cyclers
  • Next-Generation Sequencing

By Application [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Agriculture and Animal Husbandry
  • Drug Discovery
  • Forensics
  • Proteogenomic Research
  • Disease Identification
  • Diagnostics and Control
  • Others

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil
 

Some of the genomic and proteomic tool companies profiled in this report include 3Billion, Bio-Rad Laboratories, GE Healthcare, Novogene, Qiagen, Thermo Fisher Scientific, and Waters.

Lucintel forecasts that next-generation sequencing will remain the fastest growing type segment over the forecast period due to its declining cost and increasing clinical opportunities.

Within this market, proteogenomic research will remain the largest application segment over the forecast period due to increasing research and development expenditure related to proteomics and rising number of genomic research projects.

North America will remain the largest region over the forecast period due to increasing prevalance of cancer, increasing research activities related to genomics and proteomics, and presence of advanced healthcare infrastructure & research facilities in the region. 



 
Features of the Global Genomic and Proteomic Tool Market
  • Market Size Estimates: Global genomic and proteomic tool market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global genomic and proteomic tool market size by various segments, such as technology and product, type, and application in terms of value.
  • Regional Analysis: Global genomic and proteomic tool market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different technology and product, type, application, and region for the global genomic and proteomic tool market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global genomic and proteomic tool market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.



 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global genomic and proteomic tool market by technology and product (sequencing technologies (sangers sequencing & next generation sequencing, PCR technologies, flow cytometry, mass spectrometry, and nucleic acid sample preparation technologies) and separation technologies), type (sample preparation, electrophoresis, biochips and microarrays, chromatography, mass spectrometry, thermal cyclers, and next-generation sequencing), application (agriculture and animal husbandry, drug discovery, forensics, proteogenomics research, disease identification, diagnostics and control, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genomic and proteomic tool market?
Q.5 What are the business risks and threats to the global genomic and proteomic tool market?
Q.6 What are the emerging trends in this genomic and proteomic tool market and the reasons behind them?
Q.7 What are some changing demands of customers in this genomic and proteomic tool market?
Q.8 What are the new developments in this genomic and proteomic tool market? Which companies are leading these developments?
Q.9 Who are the major players in this genomic and proteomic tool market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this genomic and proteomic tool market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global genomic and proteomic tool market?

 


Report Scope


Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)		 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Technology and Product (Sequencing Technologies (Sangers Sequencing & Next Generation Sequencing, PCR Technologies, Flow Cytometry, Mass Spectrometry, and Nucleic Acid Sample Preparation Technologies) and Separation Technologies), Type (Sample Preparation, Electrophoresis, Biochips & Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, and Next-Generation Sequencing), and Application (Agriculture & Animal Husbandry, Drug Discovery, Forensics, Proteogenomics Research, Disease Identification, Diagnostics & Control, and Others)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost

Table of Contents


1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genomic and Proteomic Tool Market Trends and Forecast
3.3: Global Genomic and Proteomic Tool Market by Technology and Product
3.3.1: Sequencing Technologies 
3.3.1.1: Sangers Sequencing & Next Generation Sequencing
3.3.1.2: PCR Technologies
3.3.1.3: Flow Cytometry
3.3.1.4: Mass Spectrometry
3.3.1.5: Nucleic Acid Sample Preparation Technologies
3.3.1.6: Vitamins
3.3.2: Separation Technologies 
3.4: Global Genomic and Proteomic Tool Market by Type
3.4.1: Sample Preparation
3.4.2: Electrophoresis
3.4.3: BioChips and Microarrays
3.4.4: Chromatography
3.4.5: Mass Spectrometry
3.4.6: Thermal Cyclers
3.4.7: Next-Generation Sequencing
3.5: Global Genomic and Proteomic Tool Market by Application
3.5.1: Agriculture and Animal Husbandry
3.5.2: Drug Discovery
3.5.3: Forensics
3.5.4: Proteogenomics Research
3.5.5: Disease Identification
3.5.6: Diagnostics and Control
3.5.7: Others

4. Market Trends and Forecast Analysis by Region
4.1: Global Genomic and Proteomic Tool Market by Region
4.2: North American Genomic and Proteomic Tool Market
4.2.1: Market by Technology and Product: Sequencing Technologies (Sangers Sequencing & Next Generation Sequencing, PCR Technologies, Flow Cytometry, Mass Spectrometry, and Nucleic Acid Sample Preparation Technologies) and Separation Technologies
4.2.2: Market by Type: Sample Preparation, Electrophoresis, BioChips and Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, and Next-Generation Sequencing
4.2.3: Market by Application: Agriculture and Animal Husbandry, Drug Discovery, Forensics, Proteogenomics Research, Disease Identification, Diagnostics and Control, and Others 
4.2.4: The United States Genomic and Proteomic Tool Market
4.2.5: The Canadian Genomic and Proteomic Tool Market
4.2.6: The Mexican Genomic and Proteomic Tool Market
4.3: European Genomic and Proteomic Tool Market
4.3.1: Market by Technology and Product: Sequencing Technologies (Sangers Sequencing & Next Generation Sequencing, PCR Technologies, Flow Cytometry, Mass Spectrometry, and Nucleic Acid Sample Preparation Technologies) and Separation Technologies
4.3.2: Market by Type: Sample Preparation, Electrophoresis, BioChips and Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, and Next-Generation Sequencing 
4.3.3: Market by Application: Agriculture and Animal Husbandry, Drug Discovery, Forensics, Proteogenomics Research, Disease Identification, Diagnostics and Control, and Others 
4.3.4: The Genomic and Proteomic Tool Market of United Kingdom
4.3.5: The German Genomic and Proteomic Tool Market
4.3.6: The French Genomic and Proteomic Tool Market
4.4: APAC Genomic and Proteomic Tool Market
4.4.1: Market by Technology and Product: Sequencing Technologies (Sangers Sequencing & Next Generation Sequencing, PCR Technologies, Flow Cytometry, Mass Spectrometry, and Nucleic Acid Sample Preparation Technologies) and Separation Technologies
4.4.2: Market by Type: Sample Preparation, Electrophoresis, BioChips and Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, and Next-Generation Sequencing 
4.4.3: Market by Application: Agriculture and Animal Husbandry, Drug Discovery, Forensics, Proteogenomics Research, Disease Identification, Diagnostics and Control, and Others 
4.4.4: The Chinese Genomic and Proteomic Tool Market
4.4.5: The Indian Genomic and Proteomic Tool Market
4.4.6: The Japanese Genomic and Proteomic Tool Market
4.5: ROW Genomic and Proteomic Tool Market
4.5.1: Market by Technology and Product: Sequencing Technologies (Sangers Sequencing & Next Generation Sequencing, PCR Technologies, Flow Cytometry, Mass Spectrometry, and Nucleic Acid Sample Preparation Technologies) and Separation Technologies
4.5.2: Market by Type: Sample Preparation, Electrophoresis, BioChips and Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, and Next-Generation Sequencing 
4.5.3: Market by Application: Agriculture and Animal Husbandry, Drug Discovery, Forensics, Proteogenomics Research, Disease Identification, Diagnostics and Control, and Others 
4.5.4: Brazilian Genomic and Proteomic Tool Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genomic and Proteomic Tool Market by Technology and Product
7.1.2: Growth Opportunities for the Global Genomic and Proteomic Tool Market by Type
7.1.3: Growth Opportunities for the Global Genomic and Proteomic Tool Market by Application
7.1.4: Growth Opportunities for the Global Genomic and Proteomic Tool Market by Region
7.2: Emerging Trends in the Global Genomic and Proteomic Tool Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Genomic and Proteomic Tool Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Aquafeed  Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: 3Billion Inc. 
8.2: Bio-Rad Laboratories Inc. 
8.3: GE Healthcare
8.4: Novogene Corporation
8.5: Qiagen NV
8.6: Thermo Fisher Scientific Inc. 
8.7: Waters Corporation 
8.8: Company 8
8.9: Company 9
8.10: Company 10
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Genomic and Proteomic Tool Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Genomic and Proteomic Tool Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?